Emergent BioSolutions | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Acadia Pharmaceuticals 0 4.12M 2024-09
ALKERMES USD 0 4.65M 2025-03
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amarin USD 3K 3K 2024-12
ANI Pharmaceuticals USD 5.48M 531K 2025-03
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Exact Sciences USD 9.98M 401K 2025-03
Exelixis 23.4M 3.9M 2023-09
Glaxosmithkline 178.05M 24.73M 2024-12
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Lonza CHF 70M 11M 2024-12
Merck USD 313M 15M 2025-03
Moderna USD 1000K 5M 2025-03
Myriad Genetics USD 800K 100K 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Pacira USD 3.71M 967K 2025-03
Pfizer USD 654M 85M 2025-03
PTC Therapeutics USD 43.35M 1.24M 2024-12
Sanofi 213M 151M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
United Therapeutics USD 6.1M 1.8M 2025-03


Emergent BioSolutions Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.